Share

July 2018; 5 (4) Clinical/Scientific NotesOpen Access

Fecal microbiota transplantation associated with 10 years of stability in a patient with SPMS

Seraj Makkawi, Carlos Camara-Lemarroy, Luanne Metz
First published April 3, 2018, DOI: https://doi.org/10.1212/NXI.0000000000000459
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
4220

Share

Article Information

vol. 5 no. 4 e459
DOI: 
https://doi.org/10.1212/NXI.0000000000000459
PubMed: 
29619403
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received January 3, 2018
  • Accepted in final form February 28, 2018
  • First Published April 3, 2018.
Copyright & Usage: 
Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Seraj Makkawi, MBBS, FRCPC, ABPN, MSCS, CRND,
    2. Carlos Camara-Lemarroy, MD and
    3. Luanne Metz, MD, FRCPC
  1. Seraj Makkawi, MBBS, FRCPC, ABPN, MSCS, CRND,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Carlos Camara-Lemarroy, MD and
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Luanne Metz, MD, FRCPC
    4. Scientific Advisory Boards:

    1. (1) DSMB for the NeuroNEXT study: Ibudilast Phase II trial in progressive multiple sclerosis (2) Rick Hansen Institute: Clinical trial of Minocycline in Acute Spinal Cord injury.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. (1) Patent pending for combination of minocycline plus hydroxychloroquin in demyelinating disease

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) EMD Serono

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Multiple Sclerosis Society of Canada.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Clinical Neurosciences (S.M., C.C.-L., L.M.), Cumming School of Medicine, University of Calgary, Alberta, Canada; and King Saud Bin Abdulaziz University for Health Sciences (S.M.), Jeddah, Saudi Arabia.
  1. Correspondence
    Dr. Makkawi smakkawi{at}hotmail.com
View Full Text

Article usage

Article usage: April 2018 to April 2022

AbstractFullPdfSource
Apr 2018061894Highwire
Apr 201837278313pmc
May 2018027733Highwire
Jun 2018010929Highwire
Jun 20186189225pmc
Jul 201803241530Highwire
Aug 2018133585Highwire
Aug 201815602746pmc
Sep 2018017837Highwire
Oct 2018014644Highwire
Nov 2018013017Highwire
Dec 2018022921Highwire
Jan 2019113714Highwire
Feb 2019316811Highwire
Mar 2019016423Highwire
Apr 2019922081Highwire
May 2019619527Highwire
Jun 2019216819Highwire
Jul 2019220213Highwire
Aug 2019217529Highwire
Sep 2019213519Highwire
Oct 2019320029Highwire
Nov 2019213125Highwire
Dec 2019125223Highwire
Jan 20201013538Highwire
Feb 2020314918Highwire
Mar 2020212426Highwire
Apr 202009028Highwire
May 2020412939Highwire
Jun 2020112126Highwire
Jul 202009120Highwire
Aug 2020511620Highwire
Sep 2020412224Highwire
Oct 2020611425Highwire
Nov 2020510528Highwire
Dec 202099125Highwire
Jan 20211010425Highwire
Feb 2021512318Highwire
Mar 2021612524Highwire
Apr 2021914027Highwire
May 2021118826Highwire
Jun 2021811925Highwire
Jul 202189013Highwire
Aug 2021414829Highwire
Sep 20211011024Highwire
Oct 202148937Highwire
Nov 2021527825Highwire
Dec 202156728Highwire
Jan 202298729Highwire
Feb 202299629Highwire
Mar 20221116333Highwire
Apr 20221112024Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Advertisement